spacer
home > pmps > autumn 2019 > a vision of full integration
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Vision of Full Integration





Serialisation is an increasingly hot topic in the pharmaceutical industry all over the world. Track and trace technologies have been developed over time to increase drug safety. Some sector experts believe these will be far more efficient when applied directly to primary packaging, allowing tracking to start tracking from the vial production and to trace the information alongside the whole supply chain – from factory to end user. Besides the industry, track and trace technologies could also be important – in a patient-centred approach – for the final user, who would be able to directly access information about the drug they are going to use. For that, it is key for pharma packaging producers to investigate a comprehensive approach and test several technologies aimed at developing a digital-ready primary packaging.

The pharma industry is destined to change radically in the next decade: as international consultancy giant McKinsey stated, several drivers will transform the industry, making it considerably different from the one we currently know. First of all, modern drugs will reach many more patients than today thanks to the emergence of a new middle-class in developing countries, allowing about 1 billion new patients to consume state-of-theart medications. To serve those who cannot afford medicines, innovative private-public partnerships will create new models, and new, unconventional channels will be put in place to overcome poor infrastructure and reach patients in remote places. In developed markets, the vast majority of medical needs will be addressed with generic drugs produced and distributed at scale and with great efficiency. Alongside these drugs, integrated solutions that combine diagnostics, devices, and drugs will create new businesses. Distribution channels and patient services will also further emerge and expand, especially for eldercare and special chronic diseases, as well as a broad range of new players in home and hospital care delivery, services, and nursing. Moreover, the number of partners and handover points will significantly rise.

 

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


After his first experience as a project manager, Federico Piutti specialised in innovation, working with important consultancy firms and developing innovation projects for national and international groups. For over 10 years, he’s been managing the development of projects and collaborations with research centres, startups, universities, and other players in the innovation environment, both in Italy and abroad. Federico is also in charge of Bormioli Pharma’s open innovation initiatives, part of the corporate programme Bormioli Pharma Invents.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Ypsomed and Dexcom enter into partnership to drive closed loop system

Burgdorf/San Diego – Ypsomed (SWX:YPSN) and DexCom Inc. (NASDAQ:DXCM), the world's leading provider of continuous glucose monitoring (CGM) systems, announce their partnership to drive development of a hybrid closed loop system. The partnership is an important milestone in the further development of individualised diabetes therapy. In a first step, CGM data from Dexcom will be integrated into the mylife™ App from Ypsomed.
More info >>

White Papers

ECCRT

ECCRT

The European Centre for Clinical Research Training (ECCRT) is a professional clinical research training provider focusing on the transfer of implementable knowledge for the day-to-day activities of our participants whether being new to the industry, starters on the job, or seasoned professionals. Our mission is to facilitate Clinical Research professionals to excel in their job for the benefit of patients. We aim to achieve this by providing clinical research professionals with competencies to develop new therapies for patients quicker & more efficiently, without jeopardizing quality and safety.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement